Skip to main content
Premium Trial:

Request an Annual Quote

Ausam Biotech to Ink Licensing Deal for Proteomic-Based Diagnostic

WASHINGTON, DC, Oct. 3 – Ausam Biotechnologies is set to strike a licensing deal in the current quarter with a pair of "major US pharmaceutical companies" for its proteomic-based kidney disease diagnostic, the company’s CEO told GenomeWeb on Wednesday.

Although he would not name those companies, James McCullough did say that the product, which detects impending kidney disease my measuring amounts of albumin in an individual’s urine, has recently completed human trials and is scheduled to launch in the US "early next year."

"This represents an important product for us because of the many people in the US and around the world who develop kidney disease," McCullough said during the Biotechnology Industry Organization Venture Forum meeting here, which ends on Thursday. He added that the market for his company's test may reach $1 million between five and 10 years.

Kidney disease that can be diagnosed using Ausam’s technology can arise from a variety of primary disorders, including diabetes, McCullough said. Current tests on the market—which number more than 100—are often inaccurate.

Ausam is based in Santa Monica, Calif.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.